| Name | FR 122047 hydrochloride,1-[[4,5-bis(4-Methoxyphenyl)-2-thiazolyl]carbonyl]-4-methylpiperazinehydrochloride |
|---|
| Description | FR122047 (hydrochloride) is a selective and oral active inhibitor of COX-1 with an IC50 of 28 nM. FR122047 hydrochloride has antiplatelet, analgesic and anti-inflammatory effects in vivo[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
COX-1:28 nM (IC50) |
| References |
| Boiling Point | 562.7ºC at 760 mmHg |
|---|---|
| Molecular Formula | C23H26ClN3O3S |
| Molecular Weight | 459.98900 |
| Flash Point | 294.1ºC |
| Exact Mass | 459.13800 |
| PSA | 83.14000 |
| LogP | 4.55970 |
| Vapour Pressure | 1.1E-12mmHg at 25°C |